PortfoliosLab logoPortfoliosLab logo
GGAL vs. ZIVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GGAL vs. ZIVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Grupo Financiero Galicia S.A. (GGAL) and ZIVO Bioscience, Inc. (ZIVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GGAL achieves a 5.26% return, which is significantly higher than ZIVO's -57.82% return. Over the past 10 years, GGAL has underperformed ZIVO with an annualized return of 9.37%, while ZIVO has yielded a comparatively higher 25.93% annualized return.


GGAL

1D
-0.45%
1M
31.99%
YTD
5.26%
6M
17.58%
1Y
3.10%
3Y*
62.39%
5Y*
48.50%
10Y*
9.37%

ZIVO

1D
8.68%
1M
35.93%
YTD
-57.82%
6M
-47.27%
1Y
-73.77%
3Y*
-39.34%
5Y*
-33.49%
10Y*
25.93%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GGAL vs. ZIVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GGAL
Grupo Financiero Galicia S.A.
5.26%-11.36%289.05%92.28%8.05%8.88%-45.53%-40.38%-57.85%145.24%
ZIVO
ZIVO Bioscience, Inc.
-57.82%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-5.26%

Correlation

The correlation between GGAL and ZIVO is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.05

Correlation (10Y)
Calculated over the trailing 10-year period

0.04

Correlation (All Time)
Calculated using the full available price history since Sep 24, 2012

0.02

The correlation between GGAL and ZIVO shifts across timeframes, from 0.02 (all time) to 0.14 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GGAL:

$1.55B

ZIVO:

$14.26M

EPS

GGAL:

ARS 676.97

ZIVO:

-$2.58

PS Ratio

GGAL:

0.77

ZIVO:

118.32

Total Revenue (TTM)

GGAL:

ARS 13.01T

ZIVO:

$119.03K

Gross Profit (TTM)

GGAL:

ARS 5.27T

ZIVO:

$39.21K

EBITDA (TTM)

GGAL:

ARS 306.88B

ZIVO:

-$9.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GGAL vs. ZIVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GGAL
GGAL Risk / Return Rank: 4646
Overall Rank
GGAL Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
GGAL Sortino Ratio Rank: 4949
Sortino Ratio Rank
GGAL Omega Ratio Rank: 4848
Omega Ratio Rank
GGAL Calmar Ratio Rank: 4444
Calmar Ratio Rank
GGAL Martin Ratio Rank: 4444
Martin Ratio Rank

ZIVO
ZIVO Risk / Return Rank: 2222
Overall Rank
ZIVO Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 3434
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 3434
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 1313
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 77
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GGAL vs. ZIVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Grupo Financiero Galicia S.A. (GGAL) and ZIVO Bioscience, Inc. (ZIVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GGALZIVODifference
Sharpe ratioReturn per unit of total volatility

+0.47

Sortino ratioReturn per unit of downside risk

+0.61

Omega ratioGain probability vs. loss probability

1.08

1.01

+0.07

Calmar ratioReturn relative to maximum drawdown

0.06

-0.79

+0.85

Martin ratioReturn relative to average drawdown

0.13

-1.45

+1.58

GGAL vs. ZIVO - Sharpe Ratio Comparison

The current GGAL Sharpe Ratio is 0.04, which is higher than the ZIVO Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of GGAL and ZIVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GGAL vs. ZIVO - Drawdown Comparison

The maximum GGAL drawdown since its inception was -98.98%, roughly equal to the maximum ZIVO drawdown of -98.52%. Use the drawdown chart below to compare losses from any high point for GGAL and ZIVO.


Loading charts...

Drawdown Indicators


GGALZIVODifference

Max Drawdown

Largest peak-to-trough decline

-98.98%

-98.52%

-0.46%

Max Drawdown (1Y)

Largest decline over 1 year

-51.28%

-93.85%

+42.57%

Max Drawdown (3Y)

Largest decline over 3 years

-62.94%

-97.16%

+34.22%

Max Drawdown (5Y)

Largest decline over 5 years

-62.94%

-98.52%

+35.58%

Max Drawdown (10Y)

Largest decline over 10 years

-91.70%

-98.52%

+6.82%

Current Drawdown

Current decline from peak

-19.48%

-88.78%

+69.30%

Average Drawdown

Average peak-to-trough decline

-57.36%

-63.76%

+6.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.18%

50.79%

-26.61%

Volatility

GGAL vs. ZIVO - Volatility Comparison

The current volatility for Grupo Financiero Galicia S.A. (GGAL) is 17.53%, while ZIVO Bioscience, Inc. (ZIVO) has a volatility of 46.88%. This indicates that GGAL experiences smaller price fluctuations and is considered to be less risky than ZIVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GGALZIVODifference

Volatility (1M)

Calculated over the trailing 1-month period

17.53%

46.88%

-29.35%

Volatility (6M)

Calculated over the trailing 6-month period

37.08%

144.75%

-107.67%

Volatility (1Y)

Calculated over the trailing 1-year period

75.08%

173.95%

-98.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.54%

139.12%

-80.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

62.01%

1,082.32%

-1,020.31%

Dividends

GGAL vs. ZIVO - Dividend Comparison

GGAL's dividend yield for the trailing twelve months is around 3.84%, while ZIVO has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GGAL
Grupo Financiero Galicia S.A.
3.84%2.11%3.81%6.49%4.62%0.23%0.94%1.89%1.29%0.16%0.13%0.09%
ZIVO
ZIVO Bioscience, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

GGAL vs. ZIVO - Financials Comparison

This section allows you to compare key financial metrics between Grupo Financiero Galicia S.A. and ZIVO Bioscience, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-2.00T0.002.00T4.00T6.00T20222023202420252026
1.99T
0
(GGAL) Total Revenue
(ZIVO) Total Revenue
Please note, different currencies. GGAL values in ARS, ZIVO values in USD

Frequently Asked Questions


GGAL and ZIVO have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZIVO has higher volatility (46.88%) compared to GGAL (17.53%). In terms of maximum drawdown, GGAL dropped -98.98% vs ZIVO's -98.52%.

GGAL currently has the higher Sharpe Ratio (0.04 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GGAL and ZIVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer